Lars brings 20 years of experience in the Biotech and Pharmaceutical industry in the Quality, Manufacturing, Product Safety and Regulatory Affairs areas.
"We are delighted to welcome Lars to Sobi," said Geoffrey McDonough, President and CEO at Sobi. "Sobi has been expanding the scope and geographic area of operations and the demands and complexity of external regulations governing our business has also increased. Lars will sustain and deepen our global commitment to quality in all aspects of our work, and will be a valuable addition to our senior leadership team."
"I'm very much looking forward to joining the team at Sobi and to entering my new role - developing and delivering therapies at the highest level of quality to people living with a rare disease," said Lars Dreiøe.
Lars will join Sobi on 18 January 2016.
_________________________________________